Conmed forecasts 2026 adjusted EPS of $4.48 to $4.60 while targeting 5% to 6% organic growth — See source for full details.
$CNMD
Price history, market instrument context, member research, and related headlines in one place.
CNMD key statistics
CONMED Corporation (CNMD) is a stock instrument quoted on NYSE in USD. The most recently published price is $47.14, up $2.21 (4.92%) from the previous close of $44.93. It has traded between $45.67 and $47.76 in the latest session. Over the past year it has ranged from $31.44 to $53.66, leaving it in the upper half of its 52-week range (71%). Reported volume for the session was 401.3K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Related news
CONMED Q2 2026 slides: organic growth strong despite GI exit drag — See source for full details.